SGS Belgium — Clinical Trial Site

67 Registered trials

12 Currently recruiting

Organisation

SGS Belgium

Location

Edegem, Belgium

Identifier

ORG-100007917

Address

Drie Eikenstraat 655, 2650, Belgium

Departments

#001_00270390: Health & Nutrition
Clinical Pharmacological Unit
Clinical Pharmacology Unit
Clinical Pharmacology Unit Antwerpen
Clinical Research Clinical Pharmacology Unit
CPU
gastroenterology
SGS - Clinical Research
SGS - Clinical Research, Clinical Pharmacology Unit
SGS Belgium NV – Clinical Pharmacology Unit
SGS Clinical Pharmacology Unit
SGS Clinical Research, Clinical Pharmacology Unit
SGS CR - Clinical Pharmacology Unit
SGS Life Science Services - Clinical Research
SGS NV - Clinical Pharmacology Unit
SGS-Clinical Research CPU

Clinical trials at this site (67)

Search interface

A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liv… Pending

2024-515074-26-00 liver cirrhosis 1
Relative bioavailability and effect of food study with GLPG3667 in healthy subjects Pending

2026-525706-35-00 inflammatory and autoimmune diseases 3
Study to Learn How Safe EV25 is and the Amount of EV25 in the Body Over a Period of Time, When Given as a Single Dose to Adult Healthy Peopl… Recruiting

2026-525176-26-00 Influenza 3 2026-05-28
A study to test how different doses of BI 3814916 are tolerated by healthy people Recruiting

2025-523262-25-00 healthy volunteer trial 1 2026-05-11
A clinical trial of MK-6050 in healthy participants (MK-6050-002) Recruiting

2026-525625-21-00 Hidradenitis suppurativa 3 2026-04-28
A Phase 1, drug-drug interaction trial of IMU-838 with oral contraceptives in women Recruiting

2026-525208-90-00 Multiple sclerosis 3 2026-04-01
A clinical trial of MK-7228 in adults (MK-7228-002) Recruiting

2025-522147-18-00 Atherosclerosis 3 2026-03-30
A Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic … Recruiting

2025-523826-41-00 Dermatitis atopic 1 2026-02-25
A study to evaluate how well single and multiple doses of O3R-5671-PRO are tolerated in healthy adult subjects Recruiting

2025-522571-28-00 Inflammatory bowel diseases and psoriasis. 1 2025-08-28
Phase 1, Randomized, Double-blind, Placebo-Controlled, First-in-Human Single Ascending Dose Study in Healthy Participants to Assess the Safe… Recruiting

2024-517644-62-00 Mild to Moderate Asthma 1 2025-06-30
A three-part trial in healthy volunteers to find out how long icotrokinra stays in and acts on the body when administered as different table… Recruiting

2025-521005-41-00 Inflammatory Conditions 3 2025-06-30
A first-in-human trial to evaluate safety, tolerability, and pharmacokinetics of single and multiple oral doses of Debio 1453P in healthy ad… Recruiting

2024-519328-26-01 Sexual Transmitted Infection (STI) 1 2025-06-18
A clinical study of the V540C vaccine in healthy adults (V540C-003) Recruiting

2024-518863-36-00 Human Papilloma virus 1 2025-05-27
A study to test how well different doses of BI 3804379 are tolerated by healthy people and patients with MASH Recruiting

2024-513549-36-01 Metabolic Dysfunction-associated Steatohepatitis 1 2024-09-10
A study to evaluate the safety and tolerability of JNJ-90106848 and to investigate how long JNJ-90106848 stays in and acts on the body (phar… Ended

2025-521004-21-00 Inflammatory Conditions 1 2025-08-21
A Study to Evaluate Tobevibart+Elebsiran versus Bulevirtide in Chronic HDV Infection Ended

2024-520062-54-00 Chronic Hepatitis D Virus (HDV) Infection 4 2025-07-23
A clinical study of MK-6050 in healthy people (MK-6050-001) Ended

2025-523861-58-00 Hidradenitis suppurativa 1 2025-11-24
A study to Learn How Safe AGMB-129 is in Healthy Adults Taking Multiple Doses of AGMB-129 That Are Increased a Little at a Time Ended

2025-521705-40-00 Fibrostenotic Crohn’s disease 3 2025-07-18
Study to Learn How Safe EV25 is and the Amount of EV25 in the Body Over a Period of Time, When Taken [CCI] as a Dry Powder via the Nose by A… Ended

2025-521783-35-00 Influenza virus 3 2025-07-10
A Study to Learn How Safe Different Doses of NTS-521 are, What the Amount of NTS-521 in the Body is Over a Period of Time, and What the Effe… Ended

2024-518613-26-01 Not applicable 1 2025-06-06
A study to investigate how different tablet types of balinatunfib and food will influence the absorption of balinatunfib in blood in healthy… Ended

2024-519860-41-00 Immune system diseases 3 2025-06-02
A study to test how well multiple doses of BI 3810477 are tolerated by healthy adults. Ended

2024-519327-20-00 Healthy volunteer trial 3 2025-05-21
Drug-Drug Interaction Study With BIA 28-6156 and Clarithromycin, Midazolam, and Dabigatran Etexilate in Healthy Participants Ended

2025-520840-14-00 Healthy volunteers 3 2025-04-29
A clinical study of MK-1403 in healthy people (MK-1403-002) Ended

2023-507239-39-00 Atherosclerosis 3 2025-04-25